L01EA04 Bosutinib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 3 drugs in this drug class.
- 3 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01EA04 Bosutinib 3 drugs
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Bosutinib (bosutinib dihydrate) 1 drug
- Bosutinib (bosutinib monohydrate) 2 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Bosulif (Pfizer Canada, 100 mg, 500 mg) PM | prescription (Rx) |
| Bosulif (Pfizer Canada, 400 mg) PM | prescription (Rx) |
| Reddy-Bosutinib PM | prescription (Rx) |
Other classes of the same level
- L01EA01 Imatinib 15 drugs
- L01EA02 Dasatinib 6 drugs
- L01EA03 Nilotinib 4 drugs
- L01EA05 Ponatinib 1 drug
- L01EA06 Asciminib 1 drug
Other names of the drug class
- English (United Kingdom): L01EA04 bosutinib
- German: L01EA04 Bosutinib
- German (Austria): L01EA04 Bosutinib
- Italian: L01EA04 BOSUTINIB
- Turkish: L01EA04 bosutinib
- Czech: L01EA04 Bosutinib
- Spanish: L01EA04 Bosutinib
- German (Switzerland): L01EA04 Bosutinib
- French (Switzerland): L01EA04 Bosutinib
- Italian (Switzerland): L01EA04 Bosutinib
- Dutch: L01EA04 Bosutinib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EA04
Ask your doctor or pharmacist for advice.